SEGLUROMET

This brand name is authorized in United States. It is also authorized in Australia, Austria, Cyprus, Estonia, Finland, Ireland, Israel, Lithuania, Netherlands, Poland, Romania, Spain.

Active ingredients

The drug SEGLUROMET contains a combination of these active pharmaceutical ingredients (APIs):

1	Ertugliflozin UNII MLU731K321 - ERTUGLIFLOZIN PIDOLATE
	Ertugliflozin helps to lower blood glucose by making the patient pass out glucose in the urine. It does this by blocking a protein in the kidneys (called SGLT2) that normally takes glucose back into the blood from the kidneys.
	Read more about Ertugliflozin
2	Metformin UNII 786Z46389E - METFORMIN HYDROCHLORIDE
	Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.
	Read more about Metformin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SEGLUROMET Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BD23	Metformin and ertugliflozin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BD Combinations of oral blood glucose lowering drugs
Discover more medicines within A10BD23

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11562M, 11563N, 11564P, 11568W, 11569X, 11575F, 11581M, 11584Q
EE	Ravimiamet	1767630, 1767641, 1767652, 1767663, 1767674, 1767685, 1767696, 1767708, 1767719, 1767720, 1767731, 1767742, 1767753, 1767764, 1767775, 1767786, 1767797, 1767809, 1767810, 1767821, 1767832, 1767843, 1767854, 1767865, 1767876, 1767887, 1767898, 1767900, 1777709, 1777710, 1777721, 1777732
ES	Centro de información online de medicamentos de la AEMPS	1181265011, 1181265025
FI	Lääkealan turvallisuus- ja kehittämiskeskus	088817, 459845, 489128, 511418
IL	מִשְׂרַד הַבְּרִיאוּת	8309, 8310
LT	Valstybinė vaistų kontrolės tarnyba	1085295, 1085296, 1085297, 1085298, 1085299, 1085300, 1085301, 1085302, 1085303, 1085304, 1085305, 1085306, 1085307, 1085308, 1085309, 1085310, 1085311, 1085312, 1085313, 1085314, 1085315, 1085316, 1085317, 1085318, 1085319, 1085320, 1085321, 1085322, 1086580, 1086581, 1086582, 1086583
NL	Z-Index G-Standaard, PRK	167711, 167738
PL	Rejestru Produktów Leczniczych	100403947, 100404668, 100404674, 100404680
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66529001, W66529002, W66529003, W66529004, W66530001, W66530002, W66530003, W66530004
US	FDA, National Drug Code	0006-5369, 0006-5370, 0006-5373, 0006-5374